The Pro-inflammatory Effects of Glucocorticoids in the Brain
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are a class of steroid hormones derived from cholesterol. Their actions are mediated by the glucocorticoid and mineralocorticoid receptors, members of the superfamily of nuclear receptors, which, once bound to their ligands, act as transcription factors that can directly modulate gene expression. Through protein-protein interactions with other transcription factors, they can also regulate the activity of many genes in a composite or tethering way. Rapid non-genomic signaling was also demonstrated since glucocorticoids can act through membrane receptors and activate signal transduction pathways, such as protein kinases cascades, to modulate other transcriptions factors and activate or repress various target genes. By all these different mechanisms, glucocorticoids regulate numerous important functions in a large variety of cells, not only in the peripheral organs but also in the central nervous system during development and adulthood. In general, glucocorticoids are considered anti-inflammatory and protective agents due to their ability to inhibit gene expression of pro-inflammatory mediators and other possible damaging molecules. Nonetheless, recent studies have uncovered situations in which these hormones can act as pro-inflammatory agents depending on the dose, chronicity of exposure, and the structure/organ analyzed. In this review, we will provide an overview of the conditions under which these phenomena occur, a discussion that will serve as a basis for exploring the mechanistic foundation of glucocorticoids pro-inflammatory gene regulation in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 5×
“J Neuroendocrinol (2012) 24(1):174–82.”
BackgroundInfluentialMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 3×
“J Allergy Clin Immunol (2013) 132(5):1033–44.”
BackgroundMicroglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · cited 4×
“This domain is functionally important, since it is required for transcriptional activity of steroid hormones; (2) the DNA-binding domain (DBD), which binds to the glucocorticoid responsive elements (GRE) sites in the promoter region of target genes; and (3) ligand-binding domain (LBD) that contains the binding domain…”
BackgroundInfluentialThe biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Chromatin accessibility pre-determines glucocorticoid receptor binding patterns
John, S., Sabo, P. J., Thurman, R. E., Sung, M.-H., Biddie, S. C., Johnson, T. A., Hager, G. L., & Stamatoyannopoulos, J. A. (2011) · Nature Genetics · doi:10.1038/ng.759 · Cited by 954 · cited 1×
“In addition, the recruitment of the GC–GR and their regulatory elements, as coactivators and RNA polymerase II to DNA binding, is also dependent on the existence of accessible chromatin, which appears to be cell type specific (29).”
Background
Research works printed but not linked: 49
- Palm, 2009, Pattern recognition receptors and control of adaptive immunity, Immunol Rev, 227, 221, 10.1111/j.1600-065X.2008.00731.x · DOI · Paper page
- Akira, 2011, Innate immunity and adjuvants, Philos Trans R Soc Lond B Biol Sci, 366, 2748, 10.1098/rstb.2011.0106 · DOI · Paper page
- Medzhitov, 2010, Inflammation 2010: new adventures of an old flame, Cell, 140, 771, 10.1016/j.cell.2010.03.006 · DOI · Paper page
- Wensveen, 2015, NK cells link obesity-induced adipose stress to inflammation and insulin resistance, Nat Immunol, 16, 376, 10.1038/ni.3120 · DOI · Paper page
- Golia, 2014, Inflammation and cardiovascular disease: from pathogenesis to therapeutic target, Curr Atheroscler Rep, 16, 435, 10.1007/s11883-014-0435-z · DOI · Paper page
- Muller-Ladner, 2005, Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis, Nat Clin Pract Rheumatol, 1, 102, 10.1038/ncprheum0047 · DOI · Paper page
- Baumgart, 2012, Crohn’s disease, Lancet, 380, 1590, 10.1016/S0140-6736(12)60026-9 · DOI · Paper page
- Pedersen, 2014, Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation, Trends Mol Med, 20, 652, 10.1016/j.molmed.2014.09.006 · DOI
- Sousa, 2000, Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform, J Allergy Clin Immunol, 105, 943, 10.1067/mai.2000.106486 · DOI · Paper page
- Wenzel, 2012, Severe asthma: from characteristics to phenotypes to endotypes, Clin Exp Allergy, 42, 650, 10.1111/j.1365-2222.2011.03929.x · DOI · Paper page
- Esser, 2015, Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease, Expert Opin Investig Drugs, 24, 283, 10.1517/13543784.2015.974804 · DOI · Paper page
- Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 · DOI · Paper page
- Colotta, 2009, Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, Carcinogenesis, 30, 1073, 10.1093/carcin/bgp127 · DOI · Paper page
- Schweingruber, 2012, Mechanisms of glucocorticoids in the control of neuroinflammation, J Neuroendocrinol, 24, 174, 10.1111/j.1365-2826.2011.02161.x · DOI · Paper page
- Beato, 2000, Steroid hormone receptors: an update, Hum Reprod Update, 6, 225, 10.1093/humupd/6.3.225 · DOI · Paper page
- Sakamoto, 2012, Rapid signaling of steroid hormones in the vertebrate nervous system, Front Biosci (Landmark Ed), 17, 996, 10.2741/3970 · DOI
- Ligr, 2012, Mifepristone inhibits GRbeta coupled prostate cancer cell proliferation, J Urol, 188, 981, 10.1016/j.juro.2012.04.102 · DOI
- Shahidi, 1999, Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia, Biochem Biophys Res Commun, 254, 559, 10.1006/bbrc.1998.9980 · DOI
- Carruthers, 2015, Phosphorylation of glucocorticoid receptor tau1c transactivation domain enhances binding to CREB binding protein (CBP) TAZ2, Biochem Biophys Res Commun, 457, 119, 10.1016/j.bbrc.2014.12.021 · DOI
- Li, 2011, A retrospective on nuclear receptor regulation of inflammation: lessons from GR and PPARs, PPAR Res, 2011, 742785, 10.1155/2011/742785 · DOI
- Falkenstein, 2000, Multiple actions of steroid hormones – a focus on rapid, nongenomic effects, Pharmacol Rev, 52, 513
- De Bosscher, 2006, Cross-talk between nuclear receptors and nuclear factor kappaB, Oncogene, 25, 6868, 10.1038/sj.onc.1209935 · DOI · Paper page
- Karin, 2001, AP-1 – glucocorticoid receptor crosstalk taken to a higher level, J Endocrinol, 169, 447, 10.1677/joe.0.1690447 · DOI · Paper page
- Whitehead, 1997, cAMP response element-binding protein phosphorylation and DNA binding activity are increased in the anterior pituitary gland following glucocorticoid depletion, J Mol Endocrinol, 19, 291, 10.1677/jme.0.0190291 · DOI
- Bartholome, 2004, Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis, FASEB J, 18, 70, 10.1096/fj.03-0328com · DOI · Paper page
- Boncompagni, 2015, Membrane glucocorticoid receptors are localised in the extracellular matrix and signal through the MAPK pathway in mammalian skeletal muscle fibres, J Physiol, 593, 2679, 10.1113/JP270502 · DOI
- Sionov, 2006, Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis, J Exp Med, 203, 189, 10.1084/jem.20050433 · DOI · Paper page
- Sundahl, 2015, Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds, Pharmacol Ther, 152, 28, 10.1016/j.pharmthera.2015.05.001 · DOI · Paper page
- Smith, 2010, Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes, Prog Brain Res, 182, 1, 10.1016/S0079-6123(10)82001-1 · DOI · Paper page
- Sorrells, 2014, Glucocorticoids increase excitotoxic injury and inflammation in the hippocampus of adult male rats, Neuroendocrinology, 100, 129, 10.1159/000367849 · DOI
- Lehnardt, 2010, Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury, Glia, 58, 253, 10.1002/glia.20928 · DOI · Paper page
- Juedes, 2001, Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis, J Immunol, 166, 5168, 10.4049/jimmunol.166.8.5168 · DOI · Paper page
- Olson, 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs, J Immunol, 173, 3916, 10.4049/jimmunol.173.6.3916 · DOI · Paper page
- Frank, 2010, Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo, J Neuroimmunol, 226, 181, 10.1016/j.jneuroim.2010.05.022 · DOI · Paper page
- Chapman, 2010, Synaptic correlates of increased cognitive vulnerability with aging: peripheral immune challenge and aging interact to disrupt theta-burst late-phase long-term potentiation in hippocampal area CA1, J Neurosci, 30, 7598, 10.1523/JNEUROSCI.5172-09.2010 · DOI · Paper page
- Hermoso, 2004, Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression, Mol Cell Biol, 24, 4743, 10.1128/MCB.24.11.4743-4756.2004 · DOI · Paper page
- Meylan, 2006, Intracellular pattern recognition receptors in the host response, Nature, 442, 39, 10.1038/nature04946 · DOI · Paper page
- Man, 2015, Regulation of inflammasome activation, Immunol Rev, 265, 6, 10.1111/imr.12296 · DOI · Paper page
- Ding, 2010, Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells, J Pharmacol Exp Ther, 335, 693, 10.1124/jpet.110.171975 · DOI
- van Zoelen, 2009, Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo, Shock, 31, 280, 10.1097/SHK.0b013e318186262d · DOI · Paper page
- Briet, 2010, Aldosterone: effects on the kidney and cardiovascular system, Nat Rev Nephrol, 6, 261, 10.1038/nrneph.2010.30 · DOI · Paper page
- Azibani, 2013, Aldosterone mediates cardiac fibrosis in the setting of hypertension, Curr Hypertens Rep, 15, 395, 10.1007/s11906-013-0354-3 · DOI
- Rossignol, 2011, Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (eplerenone post-acute myocardial infarction heart failure efficacy and survival study) substudy, J Am Coll Cardiol, 58, 1958, 10.1016/j.jacc.2011.04.049 · DOI
- Herrada, 2010, Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity, J Immunol, 184, 191, 10.4049/jimmunol.0802886jimmunol.0802886 · doi:10.4049/jimmunol.0802886jimmunol.0802886
- Usher, 2010, Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice, J Clin Invest, 120, 3350, 10.1172/JCI41080 · DOI · Paper page
- Cruz-Topete, 2015, One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids, Neuroimmunomodulation, 22, 20, 10.1159/000362724 · DOI · Paper page
- Reul, 2000, The brain mineralocorticoid receptor: greedy for ligand, mysterious in function, Eur J Pharmacol, 405, 235, 10.1016/S0014-2999(00)00677-4 · DOI · Paper page
- Frieler, 2011, Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia, Stroke, 42, 179, 10.1161/STROKEAHA.110.598441 · DOI · Paper page
- Chantong, 2012, Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells, J Neuroinflammation, 9, 260, 10.1186/1742-2094-9-260 · DOI
Cited by
Liu, Q., Xi, Y., Wang, Q., Liu, J., Li, P., Meng, X., Liu, K., Chen, W., Liu, X., & Liu, Z. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.005 · Cited by 241
Profiling DNA break sites and transcriptional changes in response to contextual fear learning
Stott, R. T., Kritsky, O., & Tsai, L.-H. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249691 · Cited by 62
Saitoh, B.-Y., Tanaka, E., Yamamoto, N., Kruining, D. V., Iinuma, K., Nakamuta, Y., Yamaguchi, H., Yamasaki, R., Matsumoto, K., & Kira, J.-I. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.008 · Cited by 47
Somvanshi, P. R., Mellon, S. H., Flory, J. D., Abu-Amara, D., PTSD Systems Biology Consortium;, Wolkowitz, O. M., Yehuda, R., Jett, M., Hood, L., Marmar, C., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00065.2019 · Cited by 43
Metadata
- Authors
- Duque, E. D. A., & Munhoz, C. D.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2016-06-28
- Volume
- 7
- Pages
- 78-78
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2468703508
- Cited by
- 115
- References
- 30
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.